Folate and cancer prevention - Where to next? Counterpoint

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 9, 2008, Pages 2226-2230

  Ulrich, Cornelia M ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FLUOROURACIL; FOLIC ACID; METHOTREXATE;

BIOCHEMISTRY; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CLINICAL TRIAL; COLON CARCINOGENESIS; DNA DAMAGE; DNA METHYLATION; DRUG BIOAVAILABILITY; DRUG SAFETY; EPIGENETICS; FOLATE METABOLISM; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INTESTINE POLYP; NUCLEOTIDE METABOLISM; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH; REVIEW; VITAMIN SUPPLEMENTATION;

CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; FOLIC ACID; HUMANS; NEOPLASMS; PROGNOSIS; VARIATION (GENETICS);

EID: 53349173420     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2952     Document Type: Review

References (60)

1. Kim Y-I. Folic acid supplementation and cancer risk: Point Cancer Epidemiol Biomarkers Prev 2008;17:2220-25.
2. Wagner C. Biochemical role of folate in cellular metabolism. Folate in health and disease. New York: Marcel Dekker; 1995.
3. Nijhout HF, Reed MC, Lam SL, Shane B, Gregory JF III, Ulrich CM. In silico experimentation with a model of hepatic mitochondrial folate metabolism. Theor Biol Med Model 2006;3:40.
4. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 2002;132:2413-8S.
5. Woeller CF, Anderson DD, Szebenyi DM, Stover PJ. Evidence for small ubiquitin-like modifier-dependent nuclear import of the thymidylate biosynthesis pathway. J Biol Chem 2007;282:17623-31.
6. Laird PW. Cancer epigenetics. Hum Mol Genet 2005;14 Spec No 1:R65-76.
7. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr 2000;72:998-1003.
8. Kim YI. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 2004;13:511-9.
9. Davis S, Stacpoole PW, Bailey LB, Gregory JF III. C677T MTHFR genotype & homocysteine remethylation; effects of folate depletion. Exp Biol 2002.
10. Shelnutt KP, Kauwell GP, Gregory JF III, et al. Methylenetetrahydrofolate reductase 677C→T polymorphism affects DNA methylation in response to controlled folate intake in young women. J Nutr Biochem 2004;15:554-60.
11. Pufulete M, Al-Ghnaniem R, Khushal A, et al. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 2005;54:648-53.
12. van den Donk M, van Engeland M, Pellis L, et al. Dietary folate intake in combination with MTHFR C677T genotype and promoter methylation of tumor suppressor and DNA repair genes in sporadic colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2007;16:327-33.
13. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003;23:5293-300.
14. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 2007;104:13056-61.
15. Paz MF, Avila S, Fraga MF, et al. Germ-line variants in methylgroup metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 2002;62:4519-24.
16. Oyama K, Kawakami K, Maeda K, Ishiguro K, Watanabe G. The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer. Anticancer Res 2004;24:649-54.
17. Curtin K, Slattery ML, Ulrich CM, et al. Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 2007;28:1672-9.
18. van Engeland M, Weijenberg MP, Roemen GM, et al. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 2003;63:3133-7.
19. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 2005;113:825-8.
20. Ulrich CM. Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr 2007;86:271-3.
21. Skibola CF, Forrest MS, Coppede F, et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004;104:2155-62.
22. Skibola CF, Smith MT, Hubbard A, et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 2002;99:3786-91.
23. Skibola CF, Smith MT, Kane E, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A 1999;96:12810-5.
24. Institute of Medicine. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washingto n (DC): National Academy Press; 1998.
25. Larsson SC, Giovannucci E, Wolk A. Methionine and vitamin B6 intake and risk of pancreatic cancer: a prospective study of Swedish women and men [see comment]. Gastroenterology 2007;132:113-8.
26. Zhang SM, Moore SC, Lin J, et al. Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol 2006;163:108-15.
27. Ulrich CM. Nutrige netics in cancer research - folate metabolism and colorectal cancer. J Nutr 2005;135:2698-702.
28. Little J, Sharp L, Duthie S, Narayanan S. Colon cancer and genetic variation in folate metabolism: the clinical bottom line. J Nutr 2003;133:3758-66S.
29. Ulrich C. Genetic variability in folate-mediated one-carbon metabolism and cancer risk. In: Choi SW, Friso S, editors. Nutrient-gene interactions in cancer. Boca Raton (FL): Taylor & Francis Group; 2006. p.75-91.
30. Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2509-16.
31. Ulrich CM, Curtin K, Samowitz W, et al. MTHFR variants reduce the risk of G:C→A:T transition mutations within the p53 tumor suppressor gene in colon tumors. J Nutr 2005;135:2462-7.
32. Curtin K, Ulrich CM, Samowitz WS, et al. Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival. Int J Cancer 2007;120:2226-32.
33. Reed MC, Nijhout HF, Neuhouser ML, et al. A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J Nutr 2006;136:2653-61.
34. Ulrich CM, Nijhout HF, Reed MC. Mathematical modeling: epidemiology meets systems biology. Cancer Epidemiol Biomarkers Prev 2006;15:827-9.
35. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-9.
36. Ulrich CM, Potter JD. Folate and cancer - timing is everything. JAMA 2007;297:2408-9.
37. Kamen B. Folate and antifolate pharmacology. Semin Oncol 1997;24:S18-30-S18-39.
38. Gates SB, Mendelsohn LG, Shackelford KA, et al. Characterization of folate receptor from normal and neoplastic murine tissue: influence of dietary folate on folate receptor expression. Clin Cancer Res 1996;2:1135-41.
39. Weitman SD, Lark RH, Coney LR, et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 1992;52:3396-401.
40. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 1994;73:2432-43.
41. Dainty LA, Risinger JI, Morrison C, et al. Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma. Gynecol Oncol 2007;105:563-70.
42. Matherly LH, Hou Z, Deng Y. Human reduced folate carrier: translation of basic biology to cancer etiology and therapy. Cancer Metastasis Rev 2007;26:111-28.
43. Kelemen LE. The role of folate receptor a in cancer development, progression and treatment: cause, consequence or innocent bystander? Int J Cancer 2006;119:243-50.
44. Yang R, Kolb EA, Qin J, et al. The folate receptor a is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate. Clin Cancer Res 2007;13:2557-67.
45. Kim YI. Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen 2004;44:10-25.
46. Mason JB, Dickstein A, Jacques PF, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007;16:1325-9.
47. Luebeck EG, Moolgavkar SH. Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A 2002;99:15095-100.
48. Luebeck EG, Moolgavkar SH, Liu AY, Boynton A, Ulrich CM. Does folic-acid supplementation prevent or promote colorectal cancer? Results from model-based predictions. Cancer Epidemiol Biomarkers Prev 2008;17:1360-7.
49. American Cancer Society. Colorectal cancer facts and figures special edition 2005. Atlanta: American Cancer Society; 2005.
50. Cannon-Albright LA, Bishop DT, Samowitz W, DiSario JA, Lee R, Burt RW. Colonic polyps in an unselected population: prevalence, characteristics, and associations. Am J Gastroenterol 1994;89:827-31.
51. Ulrich CM, Potter JD. Folate supplementation: too much of a good thing? Cancer Epidemiol Biomarkers Prev 2006;15:189-93.
52. Huang EH, Carter JJ, Whelan RL, et al. Colonoscopy in mice. Surg Endosc 2002;16:22-4.
53. Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008;134:29-38.
54. Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 2008;26:665-73.
55. Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington (DC): National Academy Press; 1998.
56. Ulrich CM, Robien K, McLeod HL. Cancer pharmacogenetics: polymorphisms, pathways and beyond. Nat Rev Cancer 2003;3:912-20.
57. Robien K, Boynton A, Ulrich CM. Pharmacogenetics of folate-related drug targets in cancer treatment. Pharmacogenomics 2005;6:673-89.
58. Robien K. Folate during antifolate chemotherapy: what we know. . . and do not know. Nutr Clin Pract 2005;20:411-22.
59. Melnyk S, Pogribna M, Miller BJ, Basnakian AG, Pogribny IP, James SJ. Uracil misincorporation, DNA strand breaks, and gene amplification are associated with tumorigenic cell transformation in folate deficient/repleted Chinese hamster ovary cells. Cancer Lett 1999;146:35-44.
60. Kim YI. Role of folate in colon cancer development and progression. J Nutr 2003;133:3731-9S.